Managing abnormal liver tests in children with inflammatory bowel disease. Issue 5 (October 2021)

• Record Type: Journal Article
• Authors: van Rheenen, Patrick F.
• Is Part Of: Current opinion in pediatrics. Volume 33:Issue 5(2021)
• Publication Date: 2021-10
• Subjects: autoimmune hepatitis -- autoimmune sclerosing cholangitis -- drug-induced liver injury -- paediatric -- primary sclerosing cholangitis; Pediatrics -- Periodicals; Pediatrics -- Periodicals -- Bibliography -- Periodicals; 618.92
• DOI: 10.1097/MOP.0000000000001045
• Languages: English
• ISSNs: 1040-8703

Abstract

Abstract : Purpose of review: Liver test abnormalities in children with inflammatory bowel disease (IBD) are usually insidious in onset. By the time that symptoms referable to liver disease have appeared, the liver injury may be well advanced. It is, therefore, important that children with an incidental finding of abnormal liver tests are investigated in an appropriate and timely manner. Recent findings: The most prevalent cause of liver test elevations in paediatric IBD is immune-related liver disease, including primary sclerosing cholangitis, autoimmune sclerosing cholangitis, and autoimmune hepatitis. Although less common, drugs used in the treatment of IBD can also cause liver injury. The diagnosis of drug-induced liver injury relies largely on excluding other causes of liver injury, such as viral hepatitis, nonalcoholic fatty liver disease, and biliary and vascular complications. Summary: This review highlights an avenue to a step-wise approach for investigating children with IBD and silent liver test elevations. Central to the timing of diagnostic actions is grading the severity of liver test elevations.